Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response

Overview of attention for article published in Neurological Research and Practice, December 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 1,661 followers.

Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response https://t.co/qBEstR02wn

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.